We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+7.21%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.51B
AUM Growth
+$64.9M
Cap. Flow
-$16.6M
Cap. Flow %
-1.1%
Top 10 Hldgs %
48.71%
Holding
135
New
1
Increased
12
Reduced
42
Closed
2

Top Buys

Rank Stock Value
1
MELI icon
Mercado Libre
MELI
+$1.89M
2
CI icon
Cigna
CI
+$51.7K
3
ESAB icon
ESAB
ESAB
+$40.6K
4
KFRC icon
Kforce
KFRC
+$26.4K
5
YOU icon
Clear Secure
YOU
+$26.3K

Top Sells

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$6.65M
2
PRFT
Perficient Inc
PRFT
+$1.92M
3
AKAM icon
Akamai
AKAM
+$1.45M
4
LMT icon
Lockheed Martin
LMT
+$1.11M
5
TSLA icon
Tesla
TSLA
+$1.05M

Sector Composition

Rank Sector Weight
1 Technology 46.34%
2 Communication Services 16.36%
3 Healthcare 13.41%
4 Consumer Discretionary 11.01%
5 Financials 10.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STT icon
51
State Street
STT
$50.9B
$4.3M 0.29%
58,125
-616
-1% -$45.9K
KLIC icon
52
Kulicke & Soffa
KLIC
$5.3B
$4.3M 0.29%
87,414
PAYX icon
53
Paychex
PAYX
$40.4B
$4.23M 0.28%
35,715
-400
-1% -$48.9K
DIOD icon
54
Diodes
DIOD
$4B
$3.94M 0.26%
54,757
+284
+0.5% +$20.4K
LRCX icon
55
Lam Research
LRCX
$382B
$3.16M 0.21%
29,700
COR icon
56
Cencora
COR
$60.3B
$3.1M 0.21%
13,753
AEIS icon
57
Advanced Energy
AEIS
$12.2B
$3.08M 0.2%
28,328
CRWD icon
58
CrowdStrike
CRWD
$187B
$2.94M 0.2%
30,704
UTHR icon
59
United Therapeutics
UTHR
$26.3B
$2.87M 0.19%
9,015
-281
-3% -$74.4K
COHU icon
60
Cohu
COHU
$2.39B
$2.77M 0.18%
83,704
+521
+0.6% +$16.2K
EXEL icon
61
Exelixis
EXEL
$13.9B
$2.73M 0.18%
121,517
CAH icon
62
Cardinal Health
CAH
$53.4B
$2.7M 0.18%
27,493
ELV icon
63
Elevance Health
ELV
$81.9B
$2.62M 0.17%
4,833
SIMO icon
64
Silicon Motion
SIMO
$9.19B
$2.5M 0.17%
30,810
ENSG icon
65
The Ensign Group
ENSG
$10.1B
$2.47M 0.16%
19,981
-1,030
-5% -$123K
DGX icon
66
Quest Diagnostics
DGX
$25.1B
$2.47M 0.16%
18,025
FFIV icon
67
F5
FFIV
$22.1B
$2.4M 0.16%
13,961
PSN icon
68
Parsons
PSN
$6.28B
$2.36M 0.16%
28,790
TMO icon
69
Thermo Fisher Scientific
TMO
$211B
$2.29M 0.15%
4,137
NDSN icon
70
Nordson
NDSN
$16.5B
$2.29M 0.15%
9,854
VRTX icon
71
Vertex Pharmaceuticals
VRTX
$121B
$2.23M 0.15%
4,759
-100
-2% -$43.4K
SAIC icon
72
Saic
SAIC
$5.03B
$2.14M 0.14%
18,166
MRK icon
73
Merck
MRK
$324B
$2.13M 0.14%
17,168
UNH icon
74
UnitedHealth
UNH
$382B
$2.12M 0.14%
4,169
JKHY icon
75
Jack Henry & Associates
JKHY
$10.7B
$2.12M 0.14%
12,786

Similar funds

Oak Associates's Q2 2024 Portfolio in Review

As of Q2 2024, Oak Associates held 135 positions worth $1.51B, up 4.5% from $1.44B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Trading was light in Q2 2024: portfolio turnover was 2.2%. Oak Associates opened 1 new position and exited 2, leaving the 135-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 46% a quarter earlier, followed by Communication Services and Healthcare.

  • Oak Associates's largest Q2 2024 buy was Mercado Libre: 1,200 shares worth $1.97M.
  • Oak Associates added most to Cigna in Q2 2024, an estimated $51.7K increase.
  • Oak Associates's biggest Q2 2024 reduction was KLA, cutting an estimated $6.65M.
  • Oak Associates fully exited Perficient Inc in Q2 2024, selling an estimated $1.92M.
  • Oak Associates's ten largest holdings make up 49% of its $1.51B portfolio in Q2 2024.
  • Oak Associates opened 1 new position and closed 2 in Q2 2024.
  • Oak Associates's portfolio value rose 4.5% quarter-over-quarter to $1.51B.

Based on Oak Associates's 13F filing for Q2 2024, filed 8 Aug 2024.